Stocks and Investing
Stocks and Investing
Wed, September 13, 2023
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
[ Wed, Sep 13th 2023
] - WOPRAI
Ed Arce Reiterated (ACXP) at Strong Buy and Held Target at $13 on, Sep 13th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Acurx Pharmaceuticals, Inc." (ACXP) at Strong Buy and Held Target at $13 on, Sep 13th, 2023.
Ed, nor any peers, have made any analyst calls on ACXP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources